Your session is about to expire
← Back to Search
TRV734 for Opioid Use Disorder
Study Summary
This trial is testing if a new drug, TRV734, relieves withdrawal symptoms and has fewer side effects than oxycodone in people with OUD.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have any serious health issues that would make research participation unsafe.I have been diagnosed with severe depression that is not currently under control.I was unable to pass the consent understanding test for the study.You have experienced strong withdrawal symptoms after missing a day or two of taking methadone. We will use a special questionnaire to ask you about your withdrawal history for this study.I have no conditions that affect blood or urine tests.I am between 18 and 75 years old.I am not on medications that affect opioid effects, like certain enzyme inhibitors or drugs for withdrawal symptoms.You have experienced withdrawal symptoms when stopping opioid use or have had difficulty tolerating moderate withdrawal symptoms in the past.I am willing to give blood samples through an IV in my arm.You have been diagnosed with a particular type of mental health condition called psychotic or bipolar disorder according to the DSM-5.I am not pregnant and agree to use birth control during the study.You are okay with not taking your methadone for two to three mornings during the study, and you have done this before without experiencing severe withdrawal symptoms like vomiting, diarrhea, or other very uncomfortable symptoms.I have been on methadone for opioid addiction for over 3 months.I am considered menopausal according to my age and menstrual history.I am not pregnant or breastfeeding.I am a man who will not father a child or donate sperm for 3 months after starting the study drug.
Frequently Asked Questions
What is the approximate magnitude of participants in this research endeavor?
"Affirmative. Per the clinicaltrials.gov archives, this medical investigation is currently recruiting with a launch date of December 27th 2021 and an update made on November 23rd 2022. The trial requires 64 volunteers to be recruited from one site."
Is there an opportunity for me to join this medical experiment?
"This research requires opioid abuse sufferers aged between 18 and 75, with a total of 64 participants allowed to take part."
Has the Drug and Food Administration endorsed TRV734?
"TRV734's safety has been studied enough to receive a score of 2, as there is evidence proving its security but none which affirms its efficacy in treatment."
Is this medical trial still accepting new participants?
"Affirmative. The details hosted on clinicaltrials.gov demonstrate that this medical study, which was first published in late December of 2021, is still enrolling participants. 64 individuals are needed to be sourced from a single research site."
Are geriatric individuals excluded from this research program?
"As specified in the enrollment guidelines, individuals between 18 and 75 are eligible to participate. Moreover, there are 22 studies for minors under the age of 18 as well as 240 trials for seniors above 65."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger